DBV Technologies DBVT
NASDAQ DBVT
$13.47 -0.23 (-1.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

DBV Technologies (DBVT) Assets Average (2016 - 2026)

DBV Technologies (DBVT) posted Assets Average of $244.8 million for Q2 2026, down 2.1% sequentially from $250.0 million in Q1 2026, and up 152.38% YoY from $97.0 million in Q2 2025.

Analysis

DBV Technologies (DBVT) Assets Average (2016 - 2026) Analysis & Trends

DBV Technologies has reported Assets Average for 10 years, with the latest figure at $244.8 million in Q2 2026.

  • Quarterly Assets Average rose 152.38% year-over-year to $244.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $244.8 million (up 152.38% YoY) and the FY2025 annual result came in at $149.7 million, up 20.4% from the prior year.
  • Assets Average fell to $244.8 million in Q2 2026 per DBVT's latest filing, from $250.0 million in the prior quarter.
  • Over five years, Assets Average peaked at $266.5 million in Q3 2022 and troughed at $58.1 million in Q1 2025.
  • A 5-year average of $173.8 million and a median of $179.2 million in 2023 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2025 and 2026: Assets Average slumped 64.66% in 2025, then soared 330.3% in 2026.
  • Over 5 years, Assets Average stood at $247.3 million in 2022, then slipped by 24.64% to $186.4 million in 2023, then plunged by 57.42% to $79.4 million in 2024, then surged by 116.87% to $172.1 million in 2025, then surged by 42.24% to $244.8 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $244.8 million, $250.0 million, and $172.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 3.29 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.09 Bn
10 DBV Technologies 5.88 Bn 5.70 Bn - 244.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 244.80 Mn
Mar 31, 2026 250.05 Mn
Dec 31, 2025 172.10 Mn
Sep 30, 2025 126.96 Mn
Jun 30, 2025 97.00 Mn
Mar 31, 2025 58.11 Mn
Dec 31, 2024 79.36 Mn
Sep 30, 2024 103.62 Mn
Jun 30, 2024 130.04 Mn
Mar 31, 2024 164.44 Mn
Dec 31, 2023 186.38 Mn
Sep 30, 2023 203.65 Mn
Jun 30, 2023 225.22 Mn
Mar 31, 2023 239.72 Mn
Dec 31, 2022 247.32 Mn
Sep 30, 2022 266.55 Mn
Jun 30, 2022 201.28 Mn
Mar 31, 2022 132.15 Mn
Dec 31, 2021 158.82 Mn
Sep 30, 2021 185.75 Mn